DNA 및 유전자 클로닝 서비스 시장 규모, 점유율 및 동향 분석 보고서 : 서비스별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

DNA And Gene Cloning Services Market Size, Share & Trends Analysis Report By Service (Gene Synthesis, Custom Cloning, Sub-Cloning), By Application (DNA Sequencing, Mutagenesis, Genotyping), By End Use, By Region, And Segment Forecasts, 2025 - 2033

US $ 5,950 ￦ 8,626,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,076,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,976,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

DNA 및 유전자 클로닝 서비스 시장 개요

세계의 DNA 및 유전자 클로닝 서비스 시장 규모는 2024년 25억 1,000만 달러로 평가되었고, 2033년 94억 6,000만 달러에 이를 것으로 예측됩니다.

2025-2033년에 걸쳐 CAGR 15.98%로 성장할 전망입니다. DNA 및 유전자 클로닝 기술의 발전, 유전자 치료에 대한 수용도 증가, 맞춤형 의학에 대한 수요 증가는 시장 성장을 주도하는 주요 요인들입니다.

소요 시간, 비용, 기술적 복잡성 감소 요구

턴어라운드 시간의 단축, 비용 절감, 내부 워크플로우의 기술적 어려움 회피 필요성은 DNA 및 유전자 클로닝 서비스 수요의 주요 촉진요인입니다. 바이오테크 스타트업, 학술 연구실, 제약 회사에게 전통적인 클로닝은 특수 장비, 통제된 실험실 환경, 자격을 갖춘 분자 생물학자의 필요성으로 인해 비용이 많이 들고 시간이 오래 걸립니다. 신약 개발, 합성 생물학, 유전자 치료 부문의 경쟁 심화로 인해 조직들은 지연이나 내부 인프라 투자 없이도 첨단 역량을 확보하기 위해 클로닝을 점점 더 아웃소싱하고 있습니다.

DNA 및 유전자 클로닝 산업의 최근 기술 발전으로 유전 연구와 응용 부문이 변화하고 있습니다. 자동화 클로닝, 합성 생물학, AI 기반 유전자 설계 혁신은 비용을 획기적으로 절감하고 복잡한 워크플로우를 간소화하며 처리 시간을 단축하고 있습니다. 이러한 발전은 효율성과 정확성을 높이고 맞춤형 유전자 합성 및 클로닝 서비스의 접근성을 높여 치료제, 진단법, 연구 응용 부문의 개발 속도를 가속화합니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 DNA 및 유전자 클로닝 서비스 시장의 변수와 동향

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
• DNA 및 유전자 클로닝 서비스 시장 분석 도구
  • 산업 분석 : Porter's Five Forces
  • PESTEL 분석

제4장 DNA 및 유전자 클로닝 서비스 시장 : 서비스별, 추정 및 동향 분석

• 세계의 DNA 및 유전자 클로닝 서비스 시장의 서비스 변동 분석
• 세계의 DNA 및 유전자 클로닝 서비스 시장 규모와 동향 분석(서비스별, 2021-2033년)
• 유전자 합성
• 맞춤형 클로닝
• 서브 클로닝
• 기타

제5장 DNA 및 유전자 클로닝 서비스 시장 : 용도별, 추정 및 동향 분석

• 세계의 DNA 및 유전자 클로닝 서비스 시장의 용도 변동 분석
• 세계의 DNA 및 유전자 클로닝 서비스 시장 규모와 동향 분석(용도별, 2021-2033년)
• DNA 시퀀싱
• 돌연변이 유발
• 유전자형 분석
• 기타

제6장 DNA 및 유전자 클로닝 서비스 시장 : 최종 용도별, 추정 및 동향 분석

• 세계의 DNA 및 유전자 클로닝 서비스 시장의 최종 용도 변동 분석
• 세계의 DNA 및 유전자 클로닝 서비스 시장 규모와 동향 분석(최종 용도별, 2021-2033년)
• 학술기관 및 연구기관
• 제약 생명 공학 기업
• 위탁제조기관(CMO)과 위탁연구기관(CRO)

제7장 DNA 및 유전자 클로닝 서비스 시장 : 지역별, 추정 및 동향 분석

• 지역별 시장 점유율 분석(2024년, 2033년)
• 지역별 시장 대시보드
• 시장 규모와 예측 동향 분석(2021-2033년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 기업/경쟁의 분류
• 전략 매핑
• 기업 포지셔닝 분석(2024년)
• 기업 프로파일/목록
  • Bio-Techne
  • Charles River Laboratories
  • Eurofins Scientific
  • GenScript
  • Danaher Corporation
  • Syngene International Limited
  • Twist Bioscience
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Curia Global, Inc.

HBR

영문 목차

영문목차

DNA And Gene Cloning Services Market Summary

The global DNA and gene cloning services market size was estimated at USD 2.51 billion in 2024 and is projected to reach USD 9.46 billion by 2033, growing at a CAGR of 15.98% from 2025 to 2033. Advancements in DNA and gene cloning technology, rising acceptance of gene therapy, and increasing demand for personalized medicine are some of the factors driving market growth.

Need to reduce turnaround time, cost, and technical complexity

The need to reduce turnaround times, cut expenses, and avoid the technical difficulties of internal workflows is a major driver of demand for DNA and gene cloning services. For biotech startups, academic labs, and pharmaceutical companies, traditional cloning is costly and time-consuming due to the need for specialized equipment, controlled lab environments, and qualified molecular biologists. Organizations are increasingly outsourcing cloning to obtain advanced capabilities without delays or investment in internal infrastructure due to the growing competition in drug discovery, synthetic biology, and gene therapy.

Genetic research and applications are changing because of recent technological developments in the DNA and gene cloning industries. Automated cloning, synthetic biology, and AI-driven gene design innovations are drastically cutting costs, streamlining complicated workflows, and speeding up turnaround times. These advancements speed up the development of therapeutics, diagnostics, and research applications by increasing efficiency and accuracy, as well as making customized gene synthesis and cloning services more accessible.

Global DNA And Gene Cloning Services Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global DNA and gene cloning services market report based on service, application, end use, and region:

• Services Outlook (Revenue, USD Million, 2021 - 2033)
• Gene Synthesis
• Custom Cloning
• Sub-cloning
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• DNA Sequencing
• Mutagenesis
• Genotyping
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• CMOs & CROs
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Service Segment
  • 1.2.2. Application Segment
  • 1.2.3. End Use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. DNA and Gene Cloning Services Market Variables and Trends

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Need to reduce turnaround time, cost, and technical complexity
    • 3.2.1.2. Demand for customized constructs for CRISPR & gene editing
    • 3.2.1.3. Rising acceptance of gene therapies
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Ethical challenges with the use of gene cloning and synthesis technology
• 3.3. DNA and Gene Cloning Services Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. DNA and Gene Cloning Services Market: Service Estimates & Trend Analysis

• 4.1. Service Segment Dashboard
• 4.2. Global DNA and Gene Cloning Services Market Service Movement Analysis
• 4.3. Global DNA and Gene Cloning Services Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
• 4.4. Gene Synthesis
  • 4.4.1. Gene synthesis market estimates and forecasts 2021 to 2033 (USD Million)
• 4.5. Custom Cloning
  • 4.5.1. Custom cloning market estimates and forecasts 2021 to 2033 (USD Million)
• 4.6. Sub-cloning
  • 4.6.1. Sub-cloning market estimates and forecasts 2021 to 2033 (USD Million)
• 4.7. Others
  • 4.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. DNA and Gene Cloning Services Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global DNA and Gene Cloning Services Market Application Movement Analysis
• 5.3. Global DNA and Gene Cloning Services Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. DNA Sequencing
  • 5.4.1. DNA sequencing market estimates and forecasts 2021 to 2033 (USD Million)
• 5.5. Mutagenesis
  • 5.5.1. Mutagenesis market estimates and forecasts 2021 to 2033 (USD Million)
• 5.6. Genotyping
  • 5.6.1. Genotyping market estimates and forecasts 2021 to 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. DNA and Gene Cloning Services Market: End Use Estimates & Trend Analysis

• 6.1. End Use Segment Dashboard
• 6.2. Global DNA and Gene Cloning Services Market End Use Movement Analysis
• 6.3. Global DNA and Gene Cloning Services Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Academic & Research Institutes
  • 6.4.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
• 6.5. Pharmaceutical & Biotechnology Companies
  • 6.5.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
• 6.6. CMOs & CROs
  • 6.6.1. CMOs & CROs market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. DNA and Gene Cloning Services Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. Regulatory framework
  • 7.4.2. Canada
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Regulatory framework
  • 7.4.3. Mexico
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Regulatory framework
• 7.5. Europe
  • 7.5.1. UK
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Regulatory framework
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Regulatory framework
  • 7.5.3. France
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Regulatory framework
  • 7.5.4. Italy
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Regulatory framework
  • 7.5.5. Spain
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Regulatory framework
  • 7.5.6. Norway
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Regulatory framework
  • 7.5.7. Sweden
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Regulatory framework
  • 7.5.8. Denmark
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8.3. Competitive scenario
    • 7.5.8.4. Regulatory framework
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Regulatory framework
  • 7.6.2. China
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2.4. Regulatory framework
  • 7.6.3. India
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. Regulatory framework
  • 7.6.4. Australia
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Regulatory framework
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Regulatory framework
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Regulatory framework
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Regulatory framework
  • 7.7.2. Argentina
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Regulatory framework
• 7.8. MEA
  • 7.8.1. South Africa
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. Regulatory framework
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Regulatory framework
  • 7.8.3. UAE
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. Regulatory framework
  • 7.8.4. Kuwait
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4.3. Competitive scenario
    • 7.8.4.4. Regulatory framework

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. Bio-Techne
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Service benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Charles River Laboratories
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Service benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Eurofins Scientific
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Service benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. GenScript
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Service benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Danaher Corporation
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Service benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Syngene International Limited
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Service benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Twist Bioscience
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Service benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Thermo Fisher Scientific, Inc.
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Service benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Merck KGaA
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Service benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Curia Global, Inc.
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Service benchmarking
    • 8.4.10.4. Strategic initiatives

관련자료